These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21696055)

  • 1. Bortezomib as an adjuvant to conventional therapy in the treatment of antibody mediated rejection (AMR): the full spectrum.
    Al Meshari K; Pall A; Elgamal H; Alzayer F; Altalhi M
    Clin Transpl; 2010; ():383-90. PubMed ID: 21696055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue therapy for acute antibody mediated rejection with a proteosome inhibitor after kidney transplantation.
    Manitpisitkul W; Wilson NS; Philosophe B; Cooper M; Drachenberg C; Kukuruga D; Nogueira J; Haririan A
    Clin Transpl; 2010; ():421-8. PubMed ID: 21698839
    [No Abstract]   [Full Text] [Related]  

  • 3. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.
    Schwaiger E; Regele H; Wahrmann M; Werzowa J; Haidbauer B; Schmidt A; Böhmig GA
    Clin Transpl; 2010; ():391-6. PubMed ID: 21696056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases.
    Cooper JE; Wiseman AC; Chan L
    Clin Transpl; 2010; ():415-20. PubMed ID: 21698838
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection.
    Lubetzky M; Auli MJ; Walker J; Leeser D; Kapur S; Hartono C; Dadhania D
    Clin Transpl; 2010; ():437-40. PubMed ID: 21696061
    [No Abstract]   [Full Text] [Related]  

  • 6. Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience.
    Hardinger KL; Alford K; Murillo D
    Clin Transpl; 2010; ():429-36. PubMed ID: 21696060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib alone fails to decrease donor specific anti-HLA antibodies: even after one year post-treatment.
    Sberro-Soussan R; Zuberl J; Suberbielle-Boissel C; Legendre C
    Clin Transpl; 2010; ():409-14. PubMed ID: 21696059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitor treatment of antibody-mediated allograft rejection.
    Woodle ES; Alloway RR; Girnita A
    Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting alloantibody production with bortezomib: does it make more sense?
    Lee I; Constantinescu S; Gillespie A; Rao S; Silva P; Birkenbach M; Leech S; Karachristos A; Daller JA; Sifontis NM
    Clin Transpl; 2010; ():397-403. PubMed ID: 21696057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib for acute humoral rejection treatment at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City: an update.
    Leyva S; Marino LA; Alberú J; Morales-Buenrostro LE
    Clin Transpl; 2010; ():369-82. PubMed ID: 21698837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
    Sureshkumar KK; Hussain SM; Marcus RJ; Ko TY; Khan AS; Tom K; Vivas CA; Parris G; Jasnosz KM; Thai NL
    Clin Nephrol; 2012 Mar; 77(3):246-53. PubMed ID: 22377258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1.7 year follow-up after bortezomib therapy for refractory antibody mediated rejection.
    Shapiro R; Lunz J; Zeevi A; Basu A; Mapara M; Randhawa P; Tan HP; Sharma V; Humar A
    Clin Transpl; 2010; ():405-7. PubMed ID: 21696058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ; Kamoun M; Chan KM
    Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition for antibody-mediated rejection.
    Everly JJ; Walsh RC; Alloway RR; Woodle ES
    Curr Opin Organ Transplant; 2009 Dec; 14(6):662-6. PubMed ID: 19667989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC; Everly JJ; Brailey P; Rike AH; Arend LJ; Mogilishetty G; Govil A; Roy-Chaudhury P; Alloway RR; Woodle ES
    Transplantation; 2010 Feb; 89(3):277-84. PubMed ID: 20145517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
    Everly MJ; Everly JJ; Susskind B; Brailey P; Arend LJ; Alloway RR; Roy-Chaudhury P; Govil A; Mogilishetty G; Rike AH; Cardi M; Wadih G; Tevar A; Woodle ES
    Transplantation; 2008 Dec; 86(12):1754-61. PubMed ID: 19104417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature.
    Tzvetanov I; Spaggiari M; Joseph J; Jeon H; Thielke J; Oberholzer J; Benedetti E
    Transplant Proc; 2012 Dec; 44(10):2971-5. PubMed ID: 23195008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL; Murillo D
    Clin Transpl; 2011; ():401-8. PubMed ID: 22755438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.